Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gregory A Otterson

Showing results (141-150 of 157) with videos related to

Pageof 16
Sort By:
Journal of the National Comprehensive Cancer Network : JNCCN|July 15, 2018
NCCN Guidelines Insights: Non-Small Cell Lung Cancer, Version 5.2018David S Ettinger, Dara L Aisner, Douglas E Wood, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|April 14, 2017
Non-Small Cell Lung Cancer, Version 5.2017, NCCN Clinical Practice Guidelines in OncologyDavid S Ettinger, Douglas E Wood, Dara L Aisner, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|December 6, 2019
NCCN Guidelines Insights: Non-Small Cell Lung Cancer, Version 1.2020David S Ettinger, Douglas E Wood, Charu Aggarwal, et al.
The Lancet. Oncology|December 16, 2019
Entrectinib in ROS1 fusion-positive non-small-cell lung cancer: integrated analysis of three phase 1-2 trialsAlexander Drilon, Salvatore Siena, Rafal Dziadziuszko, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|March 10, 2016
NCCN Guidelines Insights: Non-Small Cell Lung Cancer, Version 4.2016David S Ettinger, Douglas E Wood, Wallace Akerley, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 14, 2021
First-Line Nivolumab Plus Ipilimumab in Advanced NSCLC: 4-Year Outcomes From the Randomized, Open-Label, Phase 3 CheckMate 227 Part 1 TrialLuis G Paz-Ares, Suresh S Ramalingam, Tudor-Eliade Ciuleanu, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|July 14, 2016
NCCN Guidelines Insights: Malignant Pleural Mesothelioma, Version 3.2016David S Ettinger, Douglas E Wood, Wallace Akerley, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|May 14, 2013
Thymomas and thymic carcinomas: Clinical Practice Guidelines in OncologyDavid S Ettinger, Gregory J Riely, Wallace Akerley, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|December 16, 2014
Non-small cell lung cancer, version 1.2015David S Ettinger, Douglas E Wood, Wallace Akerley, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|June 8, 2013
Non-small cell lung cancer, version 2.2013David S Ettinger, Wallace Akerley, Hossein Borghaei, et al.
Pageof 16

Showing results (141-150 of 157) with videos related to

Sort By:
Pageof 16
Journal of the National Comprehensive Cancer Network : JNCCN|July 15, 2018
NCCN Guidelines Insights: Non-Small Cell Lung Cancer, Version 5.2018David S Ettinger, Dara L Aisner, Douglas E Wood, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|April 14, 2017
Non-Small Cell Lung Cancer, Version 5.2017, NCCN Clinical Practice Guidelines in OncologyDavid S Ettinger, Douglas E Wood, Dara L Aisner, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|December 6, 2019
NCCN Guidelines Insights: Non-Small Cell Lung Cancer, Version 1.2020David S Ettinger, Douglas E Wood, Charu Aggarwal, et al.
The Lancet. Oncology|December 16, 2019
Entrectinib in ROS1 fusion-positive non-small-cell lung cancer: integrated analysis of three phase 1-2 trialsAlexander Drilon, Salvatore Siena, Rafal Dziadziuszko, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|March 10, 2016
NCCN Guidelines Insights: Non-Small Cell Lung Cancer, Version 4.2016David S Ettinger, Douglas E Wood, Wallace Akerley, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 14, 2021
First-Line Nivolumab Plus Ipilimumab in Advanced NSCLC: 4-Year Outcomes From the Randomized, Open-Label, Phase 3 CheckMate 227 Part 1 TrialLuis G Paz-Ares, Suresh S Ramalingam, Tudor-Eliade Ciuleanu, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|July 14, 2016
NCCN Guidelines Insights: Malignant Pleural Mesothelioma, Version 3.2016David S Ettinger, Douglas E Wood, Wallace Akerley, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|May 14, 2013
Thymomas and thymic carcinomas: Clinical Practice Guidelines in OncologyDavid S Ettinger, Gregory J Riely, Wallace Akerley, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|December 16, 2014
Non-small cell lung cancer, version 1.2015David S Ettinger, Douglas E Wood, Wallace Akerley, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|June 8, 2013
Non-small cell lung cancer, version 2.2013David S Ettinger, Wallace Akerley, Hossein Borghaei, et al.
Pageof 16